Inferior Low voltage |
Esophageal lesion characteristics
|
KCC
|
Time to regression
|
PPI
|
Antibiotics
|
|
Std.
|
-
|
Severe 8 mm ulceration, slowly resolving after 2 weeks
|
2b
|
21 days
|
2x40 mg 8 weeks | |
Std.
|
-
|
Severe 10 mm ulceration of 10 mm, slowly resolving after 2 weeks
|
2b
|
21 days
|
2x40 mg 8 weeks | |
HPSD
|
-
|
3 mm erythema
|
1
|
4 days
|
2x40 mg 4 weeks | |
HPSD
|
-
|
3 mm ulceration
|
2a
|
7 days
|
2x40 mg 4 weeks | |
HPSD
|
-
|
Two ulcerations, 3 mm each
|
2a
|
7 days
|
2x40 mg 4 weeks | |
HPSD
|
-
|
3 mm mucosal detatchment
|
2a
|
7 days
|
2x40 mg 4 weeks | Amoxicilin 5 days |
HPSD
|
+
|
5 mm ulceration
|
2a
|
14 days
|
2x40 mg 4 weeks | |
HPSD
|
-
|
7 mm ulceration, healing tentency after 14 days of followup
|
2a
|
>14 days
|
2x40 mg 4 weeks | |
HPSD
|
-
|
Tiny mucosal detachment
|
1
|
no EGD follow-up
|
2x40 mg 4 weeks | |
HPSD
|
+
|
Tiny mucosal detachment
|
1
|
7 days
|
2x40 mg 4 weeks | |
HPSD
|
-
|
Severe 12 mm ulceration, very slowy resolving
|
2b
|
12 weeks
|
2x40 mg 8 weeks, 2x20 mg 4 weeks | Amoxicilin 4 weeks |
HPSD
|
-
|
3 tiny mucosal detachments
|
2a
|
no EGD follow-up
|
2x40 mg 4 weeks | |
HPSD
|
-
|
3 mm mucosal detachment
|
2a
|
no EGD follow-up
|
2x40 mg 4 weeks | |
HPSD
|
-
|
Linear mucosal detachment, later one singular 5 mm ulceration, healed
after 14 days
|
2a
|
14 days
|
2x40 mg 4 weeks | |
HPSD
|
-
|
3 mm ulceration
|
2a
|
7 days
|
2x40 mg 4 weeks | |
Std: standard power setting; HPSD: fixed 50W power setting time to regression: time until complete healing; PPI: proton pump inhibitor. KCC: Kansas City classifcation: type 1: erythema; type 2: ulcers (2a: superfcial ulcers; 2b: deep ulcers); type 3: perforation (3a: perforation without communication with the atria; 3b: perforation with atrioesophageal fistula) 11 | Std: standard power setting; HPSD: fixed 50W power setting time to regression: time until complete healing; PPI: proton pump inhibitor. KCC: Kansas City classifcation: type 1: erythema; type 2: ulcers (2a: superfcial ulcers; 2b: deep ulcers); type 3: perforation (3a: perforation without communication with the atria; 3b: perforation with atrioesophageal fistula) 11 | Std: standard power setting; HPSD: fixed 50W power setting time to regression: time until complete healing; PPI: proton pump inhibitor. KCC: Kansas City classifcation: type 1: erythema; type 2: ulcers (2a: superfcial ulcers; 2b: deep ulcers); type 3: perforation (3a: perforation without communication with the atria; 3b: perforation with atrioesophageal fistula) 11 | Std: standard power setting; HPSD: fixed 50W power setting time to regression: time until complete healing; PPI: proton pump inhibitor. KCC: Kansas City classifcation: type 1: erythema; type 2: ulcers (2a: superfcial ulcers; 2b: deep ulcers); type 3: perforation (3a: perforation without communication with the atria; 3b: perforation with atrioesophageal fistula) 11 | Std: standard power setting; HPSD: fixed 50W power setting time to regression: time until complete healing; PPI: proton pump inhibitor. KCC: Kansas City classifcation: type 1: erythema; type 2: ulcers (2a: superfcial ulcers; 2b: deep ulcers); type 3: perforation (3a: perforation without communication with the atria; 3b: perforation with atrioesophageal fistula) 11 | Std: standard power setting; HPSD: fixed 50W power setting time to regression: time until complete healing; PPI: proton pump inhibitor. KCC: Kansas City classifcation: type 1: erythema; type 2: ulcers (2a: superfcial ulcers; 2b: deep ulcers); type 3: perforation (3a: perforation without communication with the atria; 3b: perforation with atrioesophageal fistula) 11 | Std: standard power setting; HPSD: fixed 50W power setting time to regression: time until complete healing; PPI: proton pump inhibitor. KCC: Kansas City classifcation: type 1: erythema; type 2: ulcers (2a: superfcial ulcers; 2b: deep ulcers); type 3: perforation (3a: perforation without communication with the atria; 3b: perforation with atrioesophageal fistula) 11 |